Lymphocytic leukemia remitted after chemotherapy, and both breast cancers were surgically resected and pathologically classified as invasive ductal carcinomas harboring immunohistochemically p53- and HER2-positive and HER2 amplifications identified by FISH analysis, with no metastasis to axillar lymph nodes. Here, ERBB2 is linked to invasive ductal breast carcinoma.